Skip to main navigation
logo
Logo

Site - Top Nav

  • About Iveric
  • Our Commitment
  • Why Iveric?
  • Clinical Programs
  • Investor Relations
  • Contact Us

Site - IR Nav

  • Investor Relations
  • News
  • Events & Presentations
  • Corporate Governance
    • Leadership
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financial Information
    • SEC Filings
    • Annual Reports
    • Quarterly Results
    • Key Ratios
  • IRS Form 8937
  • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
    • Analyst Coverage
  • Investor FAQs
  • Derivative Settlement
  • Contact Us

Press Releases

01.04.2023
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01.03.2023
Iveric Bio Announces the Addition of Pravin U. Dugel, MD, to its Board of Directors
12.20.2022
Iveric Bio Announces Completion of Rolling NDA Submission to FDA for Avacincaptad Pegol for the Treatment of Geographic Atrophy
12.02.2022
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11.30.2022
Iveric Bio Announces Pricing of $300 Million Public Offering of Common Stock
11.30.2022
Iveric Bio Announces Proposed Offering of Common Stock
11.17.2022
Iveric Bio Announces FDA Has Granted Breakthrough Therapy Designation for Avacincaptad Pegol for Geographic Atrophy
11.04.2022
Iveric Bio to Present at Upcoming Investor Conferences
11.03.2022
Iveric Bio Announces Submission of First Part of NDA for Rolling Review of Avacincaptad Pegol for the Treatment of Geographic Atrophy
11.03.2022
Iveric Bio Reports Third Quarter 2022 Operational Highlights and Financial Results

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page next ›
  • Last page last »

Site - Shareholder Tools

Printed Materials
Printed Materials
Email Alerts
Email Alerts
Downloads
Downloads
RSS Feeds
RSS Feeds
Print
Print
Share This
Share This
Twitter
Twitter

Site - Footer Nav

  • Contact Us
  • Careers
  • Expanded Access
  • Privacy Policy
  • Sitemap